During the past decade, AM Diabetes and Endocrinology Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AM Diabetes and Endocrinology Center" #1 sponsor was "Medtronic Diabetes" with 6 trials, followed by "Mannkind Corporation" with 4 trials sponsored, "Novartis" with 3 trials sponsored, "Andromeda Biotech Ltd." with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AM Diabetes and Endocrinology Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Insulet Corporation" with 1 trials as a collaborator, "Jaeb Center for Health Research" with 1 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "AM Diabetes and Endocrinology Center" are "Type 1 Diabetes Mellitus" (7 trials), "Diabetes Mellitus, Type 2" (5 trials), "Type 1 Diabetes" (3 trials), "Diabetes Mellitus, Type 1" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "AM Diabetes and Endocrinology Center" in a lesser frequency.

Most popular intervention types in "AM Diabetes and Endocrinology Center" are "Drug" (12 trials), "Device" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "vildagliptin" (2 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "AHCL insulin pump system" (1 trials) and "Active comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "AM Diabetes and Endocrinology Center" are 19 trials for "All" genders.

Currently, there are NaN active trials in "AM Diabetes and Endocrinology Center". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in AM Diabetes and Endocrinology Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AM Diabetes and Endocrinology Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".